Recent Advances in Antivirals for Emerging Viruses (3rd Edition)

Dear Colleagues,

This Special Issue is the continuation of our previous Special Issue entitled "Recent Advances in Antivirals for Emerging Viruses", which was published in 2021 and 2023. 

The emergence of COVID-19 is a reminder that new transmissible viruses may have global social, health, and economic impacts. Recently developed biological tools (including rapid and efficient cloning and sequencing) have advanced scientific efforts to identify the viral enzymes of important novel and re-emerging human viruses (e.g., Dengue, West Nile, Zika, Chikungunya, influenza, and now coronaviruses). At the same time, drug discovery has expanded exponentially, resulting in vast libraries of compounds that can be employed to screen direct antiviral activity. This Special Issue will highlight recent advances in antiviral drug developments, and address the following domains:

1. directly acting antivirals;
2. modifiers of immune activation;
3. inhibitors of specific cell activation pathways.

Dr. James J. Kohler
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.